Ensysce Biosciences, Inc.

Leisure Acquisition Corp., trading under the ticker LACQ, filed an 8-K with the Securities and Exchange Commission on March 27, 2020, while the blank-check vehicle was actively seeking a target business combination. The SPAC completed its initial public offering in 2018 with a stated focus on the gaming, entertainment, and leisure sectors. LACQ would later agree to merge with Ensysce Biosciences, a clinical-stage pharmaceutical company developing abuse-deterrent drug formulations, a deal that reoriented the vehicle toward the healthcare and life sciences space — a notable departure from its original industry mandate. Sign up on SpacDesk for the complete filing record, deal timeline, and fundamental data on LACQ.